Status:
UNKNOWN
WHARTON JELLY ORIGINATED MESENCHIAL STEM CELL in GONARTHROSIS
Lead Sponsor:
TC Erciyes University
Conditions:
Stem Cell
Gonarthrosis
Eligibility:
All Genders
60-65 years
Phase:
PHASE2
Brief Summary
Osteoarthritis (OA) is a progressive disease characterized by degeneration of the joint cartilage, which is involved in the immune system leading to proinflammatory cytokine and metalloproteinase rele...
Detailed Description
Osteoarthritis (OA) is a progressive disease characterized by degeneration of the articular cartilage, caused with the release of proinflammatory cytokines and metalloproteinases. Knee osteoarthritis ...
Eligibility Criteria
Inclusion
- Kellgren-Lawrence Grade II-III OA
- Between 60- 65 years old
- Those with chronic knee pain not undergoing 6 months of conservative treatment
- Body Mass Index: 25-30 kg / m2
- Patients who understand the content of the study
- Patients with written consent form
Exclusion
- Patients with Diabetes Mellitus
- Patients with septic table
- Patients with bleeding diathesis
- Patients with HIV and Hepatitis
- Body Mass Index greater than 30 kg / m2 and lower than 25 kg / m2
- Those with congenital axis disorder
- Those with malignancy
- Immunosuppressive
- Lumbar pathological findings
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04313894
Start Date
January 1 2019
End Date
December 31 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erciyes University Faculty of Medicine
Melikgazi, Kayseri, Turkey (Türkiye), 38050